Viewing StudyNCT00103779

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00103779
Status: COMPLETED
Last Update Posted: 2014-12-18
First Post: 2005-02-14
Brief Title: A Safety Study of SGN-40 in Patients With Non-Hodgkins Lymphoma
Sponsor: Seagen Inc
Organization: Seagen Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkin Lymphoma
Keywords:
Name View
Lymphoma View
Antigens CD40 View
Antibody Monoclonal View
Lymphoma Non-Hodgkin View
Lymphoma B-Cell View
Hematologic Diseases View
Immunoproliferative Disorders View
Lymphatic Diseases View
Lymphoproliferative Disorders View